Condition
Meconium Aspiration
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
2 treatments under study, led by Lucinactant
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
1Total
Phase 3 (1)
Trial Status
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Lucinactant1
- Standard Care1
Active Sponsors
- The University of Texas Health Science Center, Houston1
- Windtree Therapeutics1
- Memorial Hermann Hospital1
Top Investigators
Windtree Therapeutics
University of Texas Health Science Center at Houston- Division of Infectious Diseases
Related Conditions
- Diaphragmatic Hernia1
- Sepsis1
- Persistent Fetal Circulation Syndrome1